Pfizer’s new coronavirus vaccine looks promising with newly released information showing a highly effective vaccine with few adverse effects in trial participants. The most recent results expand previously reported trial data. An emergency use authorization application is expected very soon.
Moderna also shared positive results for their vaccine and reports that it expects to apply for emergency authorization shortly as well.